148 related articles for article (PubMed ID: 32266697)
1. Sleeve Gastroplasty Combined with the NLRP3 Inflammasome Inhibitor CY-09 Reduces Body Weight, Improves Insulin Resistance and Alleviates Hepatic Steatosis in Mouse Model.
Sun K; Wang J; Lan Z; Li L; Wang Y; Li A; Liu S; Li Y
Obes Surg; 2020 Sep; 30(9):3435-3443. PubMed ID: 32266697
[TBL] [Abstract][Full Text] [Related]
2. NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice.
Wang X; Sun K; Zhou Y; Wang H; Zhou Y; Liu S; Nie Y; Li Y
Biochem Biophys Res Commun; 2021 Jan; 534():734-739. PubMed ID: 33213837
[TBL] [Abstract][Full Text] [Related]
3. Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty.
Hajifathalian K; Mehta A; Ang B; Skaf D; Shah SL; Saumoy M; Dawod Q; Dawod E; Shukla A; Aronne L; Brown RS; Cohen DE; Dannenberg AJ; Fortune B; Kumar S; Sharaiha RZ
Gastrointest Endosc; 2021 May; 93(5):1110-1118. PubMed ID: 32861753
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet.
Zhu W; Feng PP; He K; Li SW; Gong JP
Biochem Biophys Res Commun; 2018 Oct; 505(2):523-529. PubMed ID: 30269815
[TBL] [Abstract][Full Text] [Related]
5. Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways.
Lv Y; Gao X; Luo Y; Fan W; Shen T; Ding C; Yao M; Song S; Yan L
J Nutr Biochem; 2019 Sep; 71():110-121. PubMed ID: 31325892
[TBL] [Abstract][Full Text] [Related]
6. A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.
Yang G; Lee HE; Lee JY
Sci Rep; 2016 Apr; 6():24399. PubMed ID: 27075683
[TBL] [Abstract][Full Text] [Related]
7. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism.
Wan X; Xu C; Lin Y; Lu C; Li D; Sang J; He H; Liu X; Li Y; Yu C
J Hepatol; 2016 Apr; 64(4):925-32. PubMed ID: 26639394
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and liver histopathology in metabolically unhealthy subjects do not correlate with the hepatic abundance of NLRP3 inflammasome nor circulating IL-1β levels.
Quezada N; Valencia I; Torres J; Maturana G; Cerda J; Arab JP; Fuentes JJ; Pinto C; Turiel D; Cortés V
BMJ Open Diabetes Res Care; 2021 May; 9(1):. PubMed ID: 33941551
[TBL] [Abstract][Full Text] [Related]
9. Impact of Endoscopic Sleeve Gastroplasty in Non-alcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis.
Nunes BCM; de Moura DTH; Kum AST; de Oliveira GHP; Hirsch BS; Ribeiro IB; Gomes ILC; de Oliveira CPM; Mahmood S; Bernardo WM; de Moura EGH
Obes Surg; 2023 Sep; 33(9):2917-2926. PubMed ID: 37537506
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1.
Xiang W; Yang Y; Weng L; Ye Z; Ding P; Li H; Sun J; Zeng C
Int Immunopharmacol; 2023 May; 118():110085. PubMed ID: 37018978
[TBL] [Abstract][Full Text] [Related]
11. PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice.
Sun CC; Zhang CY; Duan JX; Guan XX; Yang HH; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX; Liu SK; Zhang J
Biochem Biophys Res Commun; 2020 Mar; 523(4):1020-1026. PubMed ID: 31973813
[TBL] [Abstract][Full Text] [Related]
12. Red raspberries suppress NLRP3 inflammasome and attenuate metabolic abnormalities in diet-induced obese mice.
Zhu MJ; Kang Y; Xue Y; Liang X; García MPG; Rodgers D; Kagel DR; Du M
J Nutr Biochem; 2018 Mar; 53():96-103. PubMed ID: 29202274
[TBL] [Abstract][Full Text] [Related]
13. Effects of Chinese Medicinal Formula BNG-1 on Phosphodiesterase 3B Expression, Hepatic Steatosis, and Insulin Resistance in High Fat Diet-induced NAFLD Mice.
Guo CH; Chen WL; Liao CH; Huang K; Chen PY; Yang CP
Int J Med Sci; 2018; 15(11):1194-1202. PubMed ID: 30123057
[No Abstract] [Full Text] [Related]
14. Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesity.
Jagtap N; Kalapala R; Katakwar A; Sharma M; Aslam M; Gupta R; Rao PN; Goud R; Tandan M; Kanakagiri H; Darishetty S; Reddy DN
Indian J Gastroenterol; 2021 Dec; 40(6):572-579. PubMed ID: 34914039
[TBL] [Abstract][Full Text] [Related]
15. Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study.
Mohamed IN; Sarhan NR; Eladl MA; El-Remessy AB; El-Sherbiny M
Acta Histochem; 2018 Apr; 120(3):242-254. PubMed ID: 29482933
[TBL] [Abstract][Full Text] [Related]
16. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS.
Song HM; Li X; Liu YY; Lu WP; Cui ZH; Zhou L; Yao D; Zhang HM
Int J Mol Med; 2018 Jul; 42(1):193-207. PubMed ID: 29620148
[TBL] [Abstract][Full Text] [Related]
17. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
Front Immunol; 2019; 10():2926. PubMed ID: 31998283
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
Dwivedi DK; Jena GB
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
[TBL] [Abstract][Full Text] [Related]
20. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.
Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM
Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
